Mesothelioma patients and their families are particularly vulnerable to ill-meaning “medicine salesmen”, such as the ones portrayed in this special investigation by 60 Minutes. Take a few minutes to watch these videos and please share if you have personally experienced something similar. The only way to stop these scams is to speak up.
Adding immunotherapy to chemotherapy plus bevacizumab shows promising benefit in survival for non-epitheliod mesothelioma patients, but not across the board
The phase 3 clinical trial known as BEAT-meso, which combines chemotherapy plus bevacizumab with immunotherapy, has shown an improvement in overall survival (OS) and progression-free
